Pulmonx Ownership | Who Owns Pulmonx?
Pulmonx Ownership Summary
Pulmonx is owned by 69.02% institutional investors, 4.66% insiders, and 26.32% retail investors. Primecap management co/ca/ is the largest institutional shareholder, holding 11.61% of LUNG shares. PRIMECAP Odyssey Aggressive Growth is the top mutual fund, with 8.53% of its assets in Pulmonx shares.
LUNG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Pulmonx | 69.02% | 4.66% | 26.32% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Medical Device Stocks | 35.88% | 10.92% | 53.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Primecap management co/ca/ | 4.72M | 11.61% | $6.10M |
| Morgan stanley | 3.99M | 9.82% | $5.15M |
| Blackrock | 2.67M | 6.90% | $16.91M |
| Soleus capital management | 2.79M | 6.85% | $3.60M |
| Blackrock funding, inc. /de | 2.66M | 6.54% | $3.43M |
| Vanguard group | 2.54M | 6.21% | $5.61M |
| Exoduspoint capital management, lp | 1.94M | 4.78% | $2.51M |
| Deutsche bank ag\ | 1.16M | 2.86% | $1.50M |
| Geode capital management | 944.49K | 2.32% | $1.22M |
| Kent lake pr | 926.16K | 2.30% | $1.50M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Kent lake capital | 328.29K | 0.94% | $2.08M |
| Kent lake pr | 926.16K | 0.76% | $1.50M |
| Stonepine capital management | 768.29K | 0.40% | $991.09K |
| Nano cap new millennium growth fund l p | 157.50K | 0.19% | $203.18K |
| Birchview capital, lp | 250.22K | 0.18% | $322.79K |
| Soleus capital management | 2.79M | 0.15% | $3.60M |
| Parkman healthcare partners | 755.64K | 0.10% | $974.77K |
| Vestal point capital, lp | 830.00K | 0.06% | $1.34M |
| Cfm wealth partners | 264.04K | 0.05% | $340.61K |
| Perkins capital management | 41.00K | 0.05% | $52.89K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Kent lake pr | 926.16K | 0.76% | 926.16K |
| Vestal point capital, lp | 830.00K | 0.06% | 830.00K |
| Soleus capital management | 2.79M | 0.15% | 750.00K |
| Kent lake capital | 328.29K | 0.94% | 328.29K |
| Aqr capital management | 357.58K | 0.00% | 298.66K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Deerfield management company, l.p. (series c) | - | - | -1.89M |
| Silvercrest asset management group | - | - | -1.26M |
| Bnp paribas asset management | - | - | -1.17M |
| Victory capital management | - | - | -834.30K |
| Altium capital management lp | - | - | -815.00K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Kent lake pr | 926.16K | 0.76% | 926.16K | $1.50M |
| Vestal point capital, lp | 830.00K | 0.06% | 830.00K | $1.34M |
| Kent lake capital | 328.29K | 0.94% | 328.29K | $2.08M |
| Vanguard fiduciary trust | 281.25K | 0.00% | 281.25K | $362.81K |
| Norges bank | 151.20K | 0.00% | 151.20K | $1.03M |
Sold Out
| Holder | Change |
|---|---|
| Clearstead advisors | -1.00 |
| Nelson, van denburg & campbell wealth management group | -7.00 |
| Bryn mawr trust | -8.00 |
| Quadrant capital group | -11.00 |
| Signaturefd | -16.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 102 | -11.30% | 28,574,936 | -11.80% | 69 | 1.10% | 52 | - | 33 | -13.16% |
| Dec 31, 2025 | 20 | -81.31% | 3,105,451 | -90.25% | 7 | 0.12% | 9 | -83.33% | 6 | -80.00% |
| Sep 30, 2025 | 28 | -75.22% | 4,194,703 | -88.43% | 10 | 0.13% | 12 | -79.66% | 7 | -79.41% |
| Jun 30, 2025 | 113 | -5.83% | 36,256,146 | 0.28% | 90 | 1.10% | 58 | 3.57% | 34 | 6.25% |
| Mar 31, 2025 | 9 | -92.62% | 3,281,067 | -90.85% | 8 | 0.10% | 4 | -93.44% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| PRIMECAP Odyssey Aggressive Growth | 3.60M | 8.53% | - |
| Fidelity Small Cap Growth | 1.49M | 3.67% | - |
| Vanguard US Total Market Shares ETF | 1.16M | 2.92% | - |
| Vanguard Total Stock Mkt Idx Inv | 1.15M | 2.73% | - |
| Fidelity Select Pharmaceuticals Port | 958.75K | 2.35% | - |
| iShares Russell 2000 ETF | 876.57K | 2.08% | 7.38K |
| Xtrackers S&P 500 Swap ETF 1C | 692.75K | 1.68% | -5.11K |
| Strategic Advisers Fidelity US TtlStk | 660.30K | 1.64% | - |
| Vanguard US Opportunities Ins USD Acc | 666.79K | 1.58% | - |
| Fidelity Advisor Small Cap I | 628.39K | 1.54% | -190.41K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $6.00K |
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $1.08K |
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $3.52K |
| Mar 02, 2026 | Radhakrishnan Srikanth | Chief Science &Techn. Officer | Sell | $4.39K |
| Mar 02, 2026 | French Glendon E. III | President and CEO | Sell | $3.87K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | 15 |
| 2025 Q4 | - | 11 |
| 2025 Q3 | - | 12 |
| 2025 Q2 | 1 | 15 |
| 2025 Q1 | - | 16 |
LUNG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools